Chiron Aredia sales will top $40 mil. this year, company tells analysts at Alex. Brown.
Executive Summary
CHIRON AREDIA SALES WILL TOP $40 MIL. IN 1996, CEO Edward Penhoet told the Alex. Brown conference in Baltimore. Chiron markets Aredia (pamidronate) under a license from Ciba for hypercalcemia of malignancy, Paget's disease and osteolytic bone lesions of multiple myeloma.